Rxivist logo

A CRISPR-Cas9 Genome Engineering Platform in Primary CD4+ T Cells for the Interrogation of HIV Host Factors

By Judd F. Hultquist, Joseph Hiatt, Kathrin Schumann, Michael J. McGregor, Theodore L. Roth, Paige Haas, Jennifer Doudna, Alexander Marson, Nevan J. Krogan

Posted 19 Oct 2017
bioRxiv DOI: 10.1101/205500

CRISPR-Cas9 gene editing strategies have revolutionized our ability to engineer the human genome for robust functional interrogation of complex biological processes. We have recently adapted this technology to primary human T cells to generate a high-throughput platform for analyzing the role of host factors in pathogen infection and lifecycle. Here, we describe applications of this system to investigate HIV pathogenesis in CD4+ T cells. Briefly, CRISPR-Cas9 ribonucleoproteins (crRNPs) are synthesized in vitro and delivered to activated primary human CD4+ T cells by nucleofection. These edited cells are then validated and expanded for use in downstream cellular, genetic, or protein-based assays. Our platform supports the arrayed generation of several gene manipulations in only a few hours' time and is widely adaptable across culture conditions, infection protocols, and downstream applications. We present detailed protocols for crRNP synthesis, primary T cell culture, 96-well nucleofection, molecular validation, and HIV infection with additional considerations for guide and screen design as well as crRNP multiplexing.

Download data

  • Downloaded 2,308 times
  • Download rankings, all-time:
    • Site-wide: 3,070 out of 94,912
    • In systems biology: 80 out of 2,425
  • Year to date:
    • Site-wide: 15,850 out of 94,912
  • Since beginning of last month:
    • Site-wide: 21,890 out of 94,912

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)